在接受过导管三门干预的患者中,心房导管障碍:多学科共识
Quentin Fischer1, Kenneth A Ellenbogen2, Suneet Mittal3
1Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
JACC. Cardiovascular interventions
|July 30, 2025
概括
三管吐 (TR) 治疗,包括手术和透管治疗,携带心脏阻塞和起器需求的风险. 本综述详细介绍了这些风险,并为受影响患者提供了管理策略.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 三回 (TR) 是一种普遍的门疾病,通常需要进行干预.
- 过导管疗法为患有严重TR的高风险患者提供了替代方案.
- 三角 (TV) 和导电系统的解剖学接近带来风险.
研究的目的:
- 审查三管干预措施.
- 专注于心房导电障碍和心脏起器植入风险.
- 为了解决与心脏起器相关的不良事件,通过导管电视进行干预.
主要方法:
- 对三膜干预的当前文献的综述.
- 通过导管修复和更换三管所带来的风险分析.
- 导电障碍和心脏起器导致并发症的评估.
主要成果:
- 跨导管三管替换与心房静脉阻塞和心脏起器植入的高率有关.
- 现有的心脏起器线可以复杂化透导管程序,并可能恶化TR.
- 导电障碍是电视干预后的重大不良事件.
结论:
- 对电视干预后传导干扰的管理需要仔细考虑.
- 一个拟议的算法有助于管理患有导电问题或已经存在的患者.
- 风险分层和程序规划对于优化电视干预结果至关重要.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193
Mitral Regurgitation III: Medical Management
31
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
31
Cardiac Catheterization III: Left Heart Catheterization
213
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
213


